Loading...
Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
BACKGROUND: Breast cancer remains a major health problem worldwide, and is becoming increasingly resistant to traditional drug treatments. For instance, Adriamycin (ADR) is beneficial for the treatment of breast cancer. However, its wide application often leads to drug resistance in clinic practice,...
Na minha lista:
| Udgivet i: | BMC Complement Altern Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486132/ https://ncbi.nlm.nih.gov/pubmed/26066793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-015-0710-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|